Login

CEO Fernando Lehner Discusses BVZ Holding AG's 2017 Annual Results: An Interview | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
ESA Director General Johann Wörner Visits Avio, Symbolizing Support for Ariane 6 and VEGA C Programs | Giulio Ranzo - CEO of Avio
00:10:00
Takes a low-volume high-conviction approach|Brad Svrluga,General Partner,Primary Venture Partners
00:10:00
EFG-Hermes CEO Karim Awad on Market Trends and Investment Strategies | Karim Awad , CEO, Egypt EFG Hermes.
00:10:00
The North Star metric for Langchain is essentially developer productivity|Ali Rohde,Co-Founder and General Partner,Outset Capital
00:10:00
Kobo Resources Highlights Advancements and Opportunities at the Casso Project in West Africa
00:10:00
Corina Popescu: Leading Electrica Romania into the Future | Georgeta Corina Popescu, CEO , Societatea Energetica Electrica SA.
00:10:00
King Core's Exploration Focus and Strategic Updates Highlighted at One-to-One Mining Conference
00:10:00
Altice USA CEO on growth, cord-cutting, competition | Dexter Goei, CEO, Altice USA IncATUS:NYQ
00:10:00
Veon Ltd. Chairman and CEO Ursula Burns discusses the succession plan for the emerging-markets phone carrier.
00:10:00
Denver-Area Firm Joins Forces with EP Wealth Advisors | RYAN PARKER - CEO of EP Wealth Advisors
00:10:00
SaaSiest CEO Network: Agillic CEO Emre Gürsoy | Emre Gürsoy, CEO, Agillic A/SAGILC:CPH
00:10:00
Altius Minerals' Royalty Portfolio Positioned for Success | Brian Dalton , CEO, Altius Minerals Corp.

© 2017 - Neuhu+